BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 21685604)

  • 1. PSIP: an overview of the results and clinical implications.
    Beuscart R
    Stud Health Technol Inform; 2011; 166():3-12. PubMed ID: 21685604
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Three different cases of exploiting decision support services for adverse drug event prevention.
    Bernonille S; Nies J; Pedersen HG; Guillot B; Maazi M; Berg AL; Sarfati JC; Koutkias V
    Stud Health Technol Inform; 2011; 166():180-8. PubMed ID: 21685623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The ADE scorecards: a tool for adverse drug event detection in electronic health records.
    Chazard E; Băceanu A; Ferret L; Ficheur G
    Stud Health Technol Inform; 2011; 166():169-79. PubMed ID: 21685622
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validation of completeness, correctness, relevance and understandability of the PSIP CDSS for medication safety.
    Ammenwerth E; Hackl WO; Massari P; Darmoni S
    Stud Health Technol Inform; 2011; 166():254-9. PubMed ID: 21685631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Information contextualization in decision support modules for adverse drug event prevention.
    Nies J; Koutkias V; Kilintzis V; Guillot B; Maglaveras N; Pedersen HG; Berg AL; Skjoet P
    Stud Health Technol Inform; 2011; 166():95-104. PubMed ID: 21685615
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Medication related computerized decision support system (CDSS): make it a clinicians' partner!
    Marcilly R; Leroy N; Luyckx M; Pelayo S; Riccioli C; Beuscart-Zéphir MC
    Stud Health Technol Inform; 2011; 166():84-94. PubMed ID: 21685614
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Data mining to generate adverse drug events detection rules.
    Chazard E; Ficheur G; Bernonville S; Luyckx M; Beuscart R
    IEEE Trans Inf Technol Biomed; 2011 Nov; 15(6):823-30. PubMed ID: 21859604
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adverse drug events prevention rules: multi-site evaluation of rules from various sources.
    Chazard E; Ficheur G; Merlin B; Serrot E; ; Beuscart R
    Stud Health Technol Inform; 2009; 148():102-11. PubMed ID: 19745240
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of adverse drug events detection: data aggregation and data mining.
    Chazard E; Ficheur G; Merlin B; Genin M; Preda C; ; Beuscart R
    Stud Health Technol Inform; 2009; 148():75-84. PubMed ID: 19745237
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patient safety through intelligent procedures in medication: the PSIP project.
    Beuscart R; McNair P; Brender J;
    Stud Health Technol Inform; 2009; 148():6-13. PubMed ID: 19745230
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toward automatic detection and prevention of adverse drug events.
    Leroy N; Chazard E; Beuscart R; Beuscart-Zephir MC;
    Stud Health Technol Inform; 2009; 143():30-5. PubMed ID: 19380911
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A knowledge engineering framework towards clinical support for adverse drug event prevention: the PSIP approach.
    Koutkias V; Stalidis G; Chouvarda I; Lazou K; Kilintzis V; Maglaveras N
    Stud Health Technol Inform; 2009; 148():131-41. PubMed ID: 19745243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Implementation of a taxonomy aiming to support the design of a contextualised clinical decision support system.
    Bernonville S; Marcilly R; Messai R; Leroy N; Przewozny E; Souf N; Beuscart-Zéphir MC
    Stud Health Technol Inform; 2011; 166():74-83. PubMed ID: 21685613
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The PSIP approach to account for human factors in Adverse Drug Events: preliminary field studies.
    Riccioli C; Leroy N; Pelayo S
    Stud Health Technol Inform; 2009; 148():197-205. PubMed ID: 19745251
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Can F-MTI semantic-mined drug codes be used for adverse drug events detection when no CPOE is available?
    Merlin B; Chazard E; Pereira S; Serrot E; Sakji S; Beuscart R; Darmoni S
    Stud Health Technol Inform; 2010; 160(Pt 2):1025-9. PubMed ID: 20841839
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Scorecards: a new method to prevent adverse drug events? Preliminary results from a clinical field study.
    Marcilly R; Hackl WO; Luyckx M; Ammenwerth E
    Stud Health Technol Inform; 2011; 166():234-45. PubMed ID: 21685629
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High rates of adverse drug events in a highly computerized hospital.
    Nebeker JR; Hoffman JM; Weir CR; Bennett CL; Hurdle JF
    Arch Intern Med; 2005 May; 165(10):1111-6. PubMed ID: 15911723
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Computerised provider order entry combined with clinical decision support systems to improve medication safety: a narrative review.
    Ranji SR; Rennke S; Wachter RM
    BMJ Qual Saf; 2014 Sep; 23(9):773-80. PubMed ID: 24728888
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact evaluation of innovative technology: estimating the impact of the PSIP solutions.
    Ammenwerth E; Hackl WO; Jensen S; Lawton K; Riedmann D; Jung M
    Stud Health Technol Inform; 2011; 166():227-33. PubMed ID: 21685628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Data-mining-based detection of adverse drug events.
    Chazard E; Preda C; Merlin B; Ficheur G; ; Beuscart R
    Stud Health Technol Inform; 2009; 150():552-6. PubMed ID: 19745372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.